A Phase 3, Open-label Study Evaluating the Longterm Safety and Effectiveness of Suzetrigine in Subjects With Pain Associated With Diabetic Peripheral Neuropathy
TITLE:
The purpose of this study is to evaluate the long-term safety and tolerability of SUZ and long-term effectiveness of SUZ in treating pain associated with DPN.
MEDICAL CONTION:
Diabetic Neuropathy
AGE:
18 Years to 80 Years
SEX/GENDER:
Male & Female